ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a” (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) [NYSE: UNH]. AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of “aa-” (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companies and ratings.)

The ratings reflect UnitedHealthcare’s balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, very favorable business profile and appropriate enterprise risk management (ERM).

The revision of the outlooks to negative from stable reflects the expected deterioration in operating performance in 2025 driven by the Medicare Advantage segment. In UnitedHealth Group’s first-quarter earnings, the company noted an acceleration in trends in the Medicare Advantage segment that occurred late in the quarter. In May 2025, the company announced that trends continued to accelerate and broadened to more types of benefit offerings. Additionally, UnitedHealth Group noted that the medical costs of many Medicare Advantage beneficiaries new to UnitedHealthcare remained higher than expected. Due to the design of the Medicare Advantage program, UnitedHealthcare is unable to implement corrective pricing actions until 2026, and the issues within the Medicare Advantage segment are expected to persist for the remainder of 2025. AM Best will continue to monitor UnitedHealth Group’s operating performance and may take rating action should operating performances no longer be in line with the very strong assessment.

UnitedHealthcare’s risk-adjusted capitalization, as measured by Best’s Capital Adequacy Ratio, is at the very strong level. Capital and surplus growth is supported by retained net earnings in excess of dividends to the parent. UnitedHealthcare actively manages subsidiary risk-adjusted capital on a near- to long-term basis to ensure capital levels are supportive of premium growth. Investment risk is on the low side with a conservative asset allocation and no material exposure to equities, real estate or schedule BA assets.

UnitedHealthcare holds a substantial market share in all lines of business and on a national basis. Premiums and earnings are well-diversified by business segment and geography. Furthermore, its large membership base provides economies of scale.

UnitedHealth Group’s ERM program is developed, and the group’s risk management capabilities are aligned with its risk profile. The ERM program is dynamic and utilized in daily operations and strategic business planning. However, AM Best recognizes the missteps that have occurred within the organization, including the Change Healthcare cyber-attack as well as the issues addressed in the recent earnings announcements. AM Best evaluates UnitedHealth Group’s ERM as appropriate.

UnitedHealth Group has strong financial flexibility with material non-regulated operating cash flows from its Optum operations. Equity has shown consistent growth over the past five years, driven entirely by retained earnings despite large share repurchases and growing dividend programs. Strong liquidity is driven by favorable operating cash flows, parent company cash, a commercial paper program and a $21 billion revolving credit facility. Financial leverage at year-end 2024 was elevated at 43.7%, as measured by AM Best, and is above the company’s long-term target of 40%. Additionally, earnings before interest and tax coverage remained good but declined in 2024 to about eight times. Furthermore, UnitedHealth Group had a large amount of goodwill and intangibles on the balance sheet totaling approximately 132% of equity. There has been no history of any material impairments and acquired assets continue to contribute favorably to revenues and earnings.

A complete listing of UnitedHealth Group’s FSRs and Long-Term ICRs, as well as Short- and Long-Term IRs, is available.

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2025 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.